Kalbitor
Active substance: ecallantide
INJECTION, SOLUTION · ECALLANTIDE 10 mg/mL
United StatesActive
Marketing holder: Takeda Pharmaceuticals America, Inc.
Verified 2026-10-09 · openFDA NDC
- Source: openFDA NDC
- Countries with the substance registered: 1
Composition
- ECALLANTIDE · 10 mg/mL
Import and control
Control by country
- United Statesprescription only
Source: openFDA NDC · record 01a1208c-645f-7519-8c30-811fab7ecf31;count=1 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- 47783-101
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- SUBCUTANEOUS
Sources
- product · openFDA NDC · 47783-101 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 47783-101 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 47783-101 · Verified 2026-10-09 · open in source